This article written by Kirk Randall, Sales Director at Cryoport,
will address particular issues surrounding the logistics and
shipment of cryogenic animal health products such as
these new regenerative therapies, as they represent the
highest level of need for any organisation working with
these products. They also represent a higher level of
resource needs for the end user where the shippers often
end up serving as temporary storage units for the veterinary
clinics treating their livestock with these critical stem cell
CONTENTS
therapies for herd/flock health. The author will break the
challenges into their core components and address
solutions individually.

Comments are closed.